ArticleBMC psychiatry2026
Misophonia in a large treatment-seeking child and adolescent sample in mental health care in Germany and Austria.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMisophonia is a newly conceptualized disorder. Although its onset is usually in childhood and early adolescence, the current knowledge about etiology or treatment options for children and adolescents is still limited. This is the first study investigating treatment-seeking children and adolescents in routine mental health care with regard to misophonia symptomatology and co-occurring symptoms.
methodsIn this multi-center cross-sectional study, conducted in Germany and Austria, N = 214 participants completed measures on misophonia, anxiety, depression, posttraumatic stress disorder, obsessive-compulsive symptoms, chronic irritability, quality of life and functional impairment. The probable misophonia subsample also reported on current coping strategies and situations in which the misophonia related problems were most evident.
resultsIn the overall sample, 90.19% of the participants reported being bothered by at least one (misophonia-relevant) repetitive sound and 31.28% scored above the clinical cut-off for probable misophonia. In the probable misophonia subsample, 96.97% showed clinically significant co-occurring symptoms such as anxiety. The probable misophonia subsample reported significantly higher scores on all co-occurring symptom scales as well as higher functional impairment and lower quality of life, compared with the non-misophonia subsample. Most misophonia-related problems occurred in the company of other people (mostly classmates (68.18%)). The most frequent coping strategies were listening to music (57.81%) and leaving the room (25.00%). DISCUSSION: The high rates of reported salient repetitive sounds and misophonia symptoms in routine mental health care, particularly in comparison to non–treatment-seeking populations, highlight the need for an awareness of the disorder in mental health services, and further research on feasible diagnostic and treatment approaches for misophonia and co-occurring symptoms in children and adolescents. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.